Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EBIT (2020 - 2025)

Stemtech (STEK) has disclosed EBIT for 6 consecutive years, with -$339217.0 as the latest value for Q3 2025.

  • Quarterly EBIT rose 52.65% to -$339217.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$1.8 million through Sep 2025, down 137.57% year-over-year, with the annual reading at -$2.4 million for FY2024, 109.2% down from the prior year.
  • EBIT hit -$339217.0 in Q3 2025 for Stemtech, down from -$300988.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of $2.8 million in Q4 2022 to a low of -$3.4 million in Q3 2022.
  • Historically, EBIT has averaged -$455705.3 across 5 years, with a median of -$578991.0 in 2023.
  • Biggest five-year swings in EBIT: surged 2783.73% in 2022 and later crashed 593.0% in 2023.
  • Year by year, EBIT stood at -$104270.0 in 2021, then soared by 2783.73% to $2.8 million in 2022, then tumbled by 40.79% to $1.7 million in 2023, then plummeted by 98.0% to $33163.0 in 2024, then crashed by 1122.88% to -$339217.0 in 2025.
  • Business Quant data shows EBIT for STEK at -$339217.0 in Q3 2025, -$300988.0 in Q2 2025, and -$1.2 million in Q1 2025.